Hypoxia features as potential indicators in prognosis, immunotherapy and drug screening in hepatocellular carcinoma patients

Transl Cancer Res. 2022 Nov;11(11):3932-3934. doi: 10.21037/tcr-22-2173.

Author

Ruize Gao^{1

2}

Affiliations

¹ Department of Cancer Research, Luxembourg Institute of Health, Luxembourg, Luxembourg.
² Department of Biomedicine, University of Basel, Basel, Switzerland.

No abstract available

Publication types

Editorial
Comment